How does ruxolitinib compare with topical calcineurin inhibitors and topical steroids?

Featuring Alexandra Golant, MD | Associate Professor of DermatologyProgram Director, Dermatology ResidencyDepartment of DermatologyIcahn School of Medicine at Mount SinaiNew York, NY | Published January 31, 2022